Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Clinical trial NCT06988618 · RECRUITING
Trial details
- NCT number
- NCT06988618
- Sponsor
- Galderma R&D
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-11
- Primary completion
- 2027-11-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.